Programme
Programme 2nd December 2021 Click on the presentation titles to read about the presenters and watch the presentation recordings. Welcome and Introduction – Dr Vivek Trivedi Prof Yvonne Perrie, University of Strathclyde, Manufacturing liposomal delivery systems for the delivery of low solubility drugs Dr Satu Lakio, Nanoform Finland Ltd, Unique Controlled Expansion of Supercritical Solutions […]
STI – Yvonne Perrie – Manufacturing liposomal delivery systems for delivery of low solubility drugs
Manufacturing liposomal delivery systems for the delivery of low solubility drugsProf Yvonne PerrieUniversity of StrathclydeScotland The first speaker of the morning and the meeting was Prof Yvonne Perrie. I am sure many of you are already familiar with her work. Prof Perrie is a Professor in Drug Delivery within the Strathclyde Institute of Pharmacy and […]
STI – Alexander Kerr – Particle engineering with membrane emulsification and micro-mixing
Particle engineering with membrane emulsification and micro-mixingMr. Alexander KerrMicropore Technologies LimitedUK Mr. Alexander Kerr is Formulations Development Manager at Micropore Technologies, a market leader expert in emulsification technology. Mr. Kerr leads Micropore’s fast growing formulation development team and has led projects ranging from encapsulation for construction and self-healing materials, to high value pharmaceutical products. […]
STI – Stau Lakio – Unique controlled expansion of supercritical solutions (CESS) technology for poorl soluble APIs
Unique Controlled Expansion of Supercritical Solutions (CESS®) technology for poorly soluble APIsDr Satu LakioNanoform Finland Ltd Dr Satu Lakio works in the field of supercritical fluid. She received her PhD from University of Helsinki and then moved to Melbourne for a postdoc. She has held several positions in both industry and Academia including in AstraZeneca, Orion […]
STI – Steve Rannard – Using insolubility to your advantage – chasing long acting therapeutics
Using Insolubility to Your Advantage – Chasing Long Acting TherapeuticsProf Steve RannardUniversity of LiverpoolUK The . An event organised by the Royal Society of Chemistry’s Formulation Science & Technology (FST) Interest Group.
Programme
Programme Programme with recordings below: Wednesday, the 22nd September 2021 (UK time) 10:00 – 10:15 Welcome and Introduction – Dr Vivian ChristogianniSession 1 (Novel characterisation & innovations of adhesive formulations) – Dr Vivian Christogianni10:15 – 11:00 Prof Steven Abbott – The app-based approach to adhesion, Steven Abbott TCNF Ltd, UK 11:00 – 11:30 Toby R. […]
Registration and Deadlines
Registration and Deadlines Participation at the event is free of charge, but registration is compulsory. PLEASE REGISTER HERE Registration Deadline: November 26th, 2021Conference Date: December 2nd, 2021 We hope you can join the event. The Organising committee Dr Nikolaos Daskalakis (Centre for Process Innovation)/RSC FST Dr Shashi Rudrangi (Kent-Athlone Pharma Group)/RSC FST […]
STI – Asma Patel – Formulation strategies for poorly soluble molecules – Pharmaceutics and biopharmaceutics considerations
Formulation strategies for poorly soluble molecules – Pharmaceutics and biopharmaceutics considerationsDr Asma PatelQuotient Sciences Speaker’s Bio / Intro:Dr. Asma Patel is the Vice President of Integrated Development Services at Quotient Sciences, responsible for providing scientific and technical support to Business Development and leading the consequent design of pharmaceutical science programs. Dr. Patel possesses over […]
Registration and Deadlines
Registration and Deadlines Please REGISTER your place HERE and then SUBMIT YOUR ABSTRACT online. Participation at the event is free of charge, but registration is compulsory. Please register HERE. Abstract submissions are requested for oral presentations on adhesive formulations across Academia and Industry. Oral Abstract Submission Deadline: September 8th, 2021 Notification of Acceptance/Rejection (Oral): September 15th, […]
STI – Lyn Daintree – In-particle design – new mSAS solutions to solubility challenge
In-particle design®: new mSAS® solutions to solubility challengeDr Lyn DaintreeCrystec PharmaUK Dr Lyn Daintree gained her doctorate from the School of Pharmacy at the University of Bradford whilst working for Bradford Particle Design. She subsequently led a team developing new products for Nektar Therapeutics. Dr Lyn Daintree has extensive knowledge of formulation development using […]